We're Not Very Worried About Veritas In Silico's (TSE:130A) Cash Burn Rate
Apr 14
Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis
UpdatedApr 21, 2026
DataAggregated Company Financials
Companies14
- 7D3.1%
- 3M-6.2%
- 1Y8.7%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 1.5%, driven by gains from Shin Nippon Biomedical Laboratories of 2.6%. Meanwhile, Veritas In Silico actually underperformed within the industry, shrinking 5.1% in the last week. This takes the industry's 12 month performance to a gain of 7.6%. Earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Apr 2026 | JP¥146.5b | JP¥63.3b | -JP¥864,496,000.00 | 23.5x | -169.5x | 2.3x |
| Thu, 19 Mar 2026 | JP¥149.0b | JP¥63.2b | -JP¥944,048,000.00 | 22.5x | -157.9x | 2.4x |
| Sat, 14 Feb 2026 | JP¥154.1b | JP¥63.4b | -JP¥594,163,000.00 | 25x | -259.3x | 2.4x |
| Mon, 12 Jan 2026 | JP¥153.3b | JP¥66.9b | JP¥72.2m | 21.7x | 2123.7x | 2.3x |
| Wed, 10 Dec 2025 | JP¥160.3b | JP¥67.6b | JP¥702.4m | 18.3x | 228.2x | 2.4x |
| Fri, 07 Nov 2025 | JP¥133.0b | JP¥66.5b | JP¥1.5b | 15.6x | 91.1x | 2x |
| Sun, 05 Oct 2025 | JP¥143.6b | JP¥66.5b | JP¥1.5b | 16.6x | 98.4x | 2.2x |
| Tue, 02 Sep 2025 | JP¥149.3b | JP¥66.5b | JP¥1.5b | 16.7x | 102.3x | 2.2x |
| Thu, 31 Jul 2025 | JP¥141.4b | JP¥66.0b | JP¥1.1b | 16.5x | 125.3x | 2.1x |
| Sat, 28 Jun 2025 | JP¥140.7b | JP¥66.0b | JP¥1.1b | 16.3x | 124.5x | 2.1x |
| Mon, 26 May 2025 | JP¥131.8b | JP¥66.0b | JP¥1.1b | 16.5x | 116.3x | 2x |
| Wed, 23 Apr 2025 | JP¥131.4b | JP¥63.8b | JP¥963.0m | 14.1x | 136.5x | 2.1x |
| Fri, 21 Mar 2025 | JP¥162.4b | JP¥64.8b | JP¥927.4m | 15.5x | 175.1x | 2.5x |
| Sun, 16 Feb 2025 | JP¥168.8b | JP¥65.3b | JP¥1.0b | 14.8x | 168.5x | 2.6x |
| Tue, 14 Jan 2025 | JP¥164.8b | JP¥62.0b | JP¥440.7m | 17.8x | 373.9x | 2.7x |
| Thu, 12 Dec 2024 | JP¥162.3b | JP¥62.0b | JP¥825.9m | 17x | 196.6x | 2.6x |
| Sat, 09 Nov 2024 | JP¥157.9b | JP¥62.3b | JP¥1.5b | 20.9x | 108.4x | 2.5x |
| Mon, 07 Oct 2024 | JP¥155.6b | JP¥61.5b | JP¥1.8b | 18.2x | 84.5x | 2.5x |
| Wed, 04 Sep 2024 | JP¥164.4b | JP¥61.5b | JP¥2.1b | 20x | 77.9x | 2.7x |
| Fri, 02 Aug 2024 | JP¥160.6b | JP¥61.8b | JP¥3.2b | 23.9x | 49.6x | 2.6x |
| Sun, 30 Jun 2024 | JP¥168.9b | JP¥61.8b | JP¥3.2b | 26.7x | 52.2x | 2.7x |
| Tue, 28 May 2024 | JP¥162.6b | JP¥61.8b | JP¥3.4b | 24.9x | 48.5x | 2.6x |
| Thu, 25 Apr 2024 | JP¥180.0b | JP¥62.3b | JP¥3.3b | 14.1x | 54.7x | 2.9x |
| Sat, 23 Mar 2024 | JP¥232.5b | JP¥155.4b | JP¥8.6b | 14x | 27x | 1.5x |
| Mon, 19 Feb 2024 | JP¥229.3b | JP¥155.3b | JP¥8.7b | 14.6x | 26.4x | 1.5x |
| Wed, 17 Jan 2024 | JP¥236.1b | JP¥167.1b | JP¥8.5b | 15.7x | 27.8x | 1.4x |
| Fri, 15 Dec 2023 | JP¥231.7b | JP¥167.4b | JP¥8.7b | 14.5x | 26.7x | 1.4x |
| Sun, 12 Nov 2023 | JP¥236.0b | JP¥168.2b | JP¥9.1b | 14.5x | 25.9x | 1.4x |
| Tue, 10 Oct 2023 | JP¥239.8b | JP¥179.3b | JP¥12.8b | 15.1x | 18.8x | 1.3x |
| Thu, 07 Sep 2023 | JP¥270.0b | JP¥179.3b | JP¥12.8b | 16.9x | 21.1x | 1.5x |
| Sat, 05 Aug 2023 | JP¥274.6b | JP¥179.8b | JP¥13.7b | 17.5x | 20x | 1.5x |
| Mon, 03 Jul 2023 | JP¥282.6b | JP¥178.5b | JP¥16.2b | 17.5x | 17.4x | 1.6x |
| Wed, 31 May 2023 | JP¥282.4b | JP¥178.2b | JP¥15.9b | 16.4x | 17.7x | 1.6x |
| Fri, 28 Apr 2023 | JP¥285.9b | JP¥171.9b | JP¥13.3b | 16.5x | 21.5x | 1.7x |
Price to Earnings Ratio
21.5x
Current Industry PE
- Investors are relatively neutral on the Japanese Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 28% per year, which is driving profits down.
Industry Comparison
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | 1.52% | |
| Healthcare | 1.57% | |
| Life Sciences | 3.15% | |
| Clinical Research and Equipment | 3.15% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2395 Shin Nippon Biomedical Laboratories | JP¥1.52k | 2.6% +JP¥1.6b | 20.2% | PE15.8x | |
| 4892 Cyfuse Biomedical K.K | JP¥709.00 | 12.2% +JP¥767.2m | -28.7% | PS30.7x | |
| 4570 Immuno-Biological Laboratories | JP¥1.50k | 4.7% +JP¥624.0m | 230.8% | PE38.3x | |
| 4241 atect | JP¥830.00 | 18.9% +JP¥583.5m | 113.9% | PE27.8x | |
| 7707 Precision System Science | JP¥230.00 | 7.0% +JP¥411.9m | 17.9% | PS1.3x |